| Title |
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, May 2018
|
| DOI | 10.2147/tcrm.s145039 |
| Pubmed ID | |
| Authors |
Michael D Jain, Christina A Bachmeier, Vania H Phuoc, Julio C Chavez |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 117 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 16% |
| Student > Ph. D. Student | 15 | 13% |
| Other | 10 | 9% |
| Student > Bachelor | 10 | 9% |
| Researcher | 9 | 8% |
| Other | 15 | 13% |
| Unknown | 39 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 19% |
| Biochemistry, Genetics and Molecular Biology | 20 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 10% |
| Agricultural and Biological Sciences | 5 | 4% |
| Engineering | 5 | 4% |
| Other | 11 | 9% |
| Unknown | 42 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2022.
All research outputs
#5,341,501
of 25,382,440 outputs
Outputs from Therapeutics and Clinical Risk Management
#266
of 1,323 outputs
Outputs of similar age
#95,018
of 339,234 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 32 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,234 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.